MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities,
short-term
$105,569K
Cash and cash
equivalents
$12,057K
Prepaid expenses and
other current assets
$2,392K
Other receivables
$1,445K
Contract assets
$691K
Accounts receivable
$227K
Total current assets
$122,381K
Operating lease, right of
use assets
$17,356K
Property and equipment,
net
$6,123K
Other assets
$2,137K
Marketable securities,
long-term
$1,001K
Total assets
$148,998K
Total liabilities and
stockholders equity
$148,998K
Total stockholders
equity
$102,018K
Total liabilities
$46,980K
Accumulated deficit
-$621,600K
Accumulated other
comprehensive (loss) income
-$23K
Additional
paid-in-capital
$723,631K
Operating lease
liabilities, non-current
$25,659K
Total current
liabilities
$19,673K
Deferred revenue, net of
current portion
$1,648K
Common stock, par value
0.0001 per share,...
$10K
Accrued expenses and
other current...
$13,889K
Accounts payable
$3,503K
Operating lease
liabilities, current
$1,287K
Deferred revenue
$994K
Back
Back
Balance Sheet
Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU)
source: myfinsight.com